ProPhase Labs, Inc.(PRPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

PRPH ProPhase Labs, Inc.

Market Closed 07-02 16:04:47 EDT Delay

盘后0.0759

-0.0021-2.69%

16:04 EDT

{"stockData":{"symbol":"PRPH","market":"US","secType":"STK","nameCN":"ProPhase Labs, Inc.","latestPrice":0.078,"timestamp":1783022400000,"preClose":0.08,"halted":0,"volume":271949,"hourTrading":{"tag":"盘后","latestPrice":0.0759,"preClose":0.078,"latestTime":"16:04 EDT","volume":107396,"amount":8151.356399999999,"timestamp":1783022687572,"change":-0.0021,"changeRate":-0.026923,"amplitude":0},"delay":15,"changeRate":-0.025000000000000022,"floatShares":4326100,"shares":4737000,"eps":-11.64057,"marketStatus":"Market Closed","change":-0.002,"latestTime":"07-02 16:04:47 EDT Delay","open":0.0781,"high":0.08055,"low":0.0712,"amount":21152.599505,"amplitude":0.116875,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"otc":true,"ttmEps":-11.64057,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1783324800000},"marketStatusCode":7,"adr":0,"listingDate":1767589200000,"exchange":"PINK LIMITED","adjPreClose":0.08,"volumeRatio":1.1095611516393218},"requestUrl":"/m/hq/s/PRPH/tweets","defaultTab":"tweets","newsList":[{"id":"2648606955","title":"ProPhase Labs Q1 EPS $(0.43) Up From $(1.33) YoY, Sales $478.000K Down From $1.431M YoY","url":"https://stock-news.laohu8.com/highlight/detail?id=2648606955","media":"Benzinga","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648606955?lang=en_us&edition=fundamental","pubTime":"2026-07-01 06:00","pubTimestamp":1782856808,"startTime":"0","endTime":"0","summary":"ProPhase Labs (OTC:PRPH) reported quarterly losses of $(0.43) per share. This is a 67.67 percent increase over losses of $(1.33) per share from the same period last year.  The company reported $478.000 thousand in sales","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":"11c8fbbf839f433c9d274cef5f173382","theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.benzinga.com/news/earnings/26/06/60205858/prophase-labs-q1-eps-0-43-1-33-yoy-sales-478-000k-down-1-431m-yoy","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"ProPhase Labs Q1 EPS $(0.43) Up From $(1.33) YoY, Sales $478.000K Down From $1.431M YoY","news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648562970","title":"Prophase Labs Q1 FY26 Operating Loss Widens to $5.4 Million; Revenue Drops 64.29% to $0.5 Million","url":"https://stock-news.laohu8.com/highlight/detail?id=2648562970","media":"Reuters","labels":["dataReport","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648562970?lang=en_us&edition=fundamental","pubTime":"2026-07-01 04:51","pubTimestamp":1782852705,"startTime":"0","endTime":"0","summary":"ProPhase Labs Q1 FY26 operating loss widens to $5.4 million; revenue drops 64.29% to $0.5 millionProPhase Labs posted a net loss from continuing operations of $5.4 million, or $(0.43) per share, for t","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL60chJ2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647304007","title":"US FDA - to Provide Early Technical Guidance in Precheck Pilot Phase 1","url":"https://stock-news.laohu8.com/highlight/detail?id=2647304007","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647304007?lang=en_us&edition=fundamental","pubTime":"2026-06-30 04:26","pubTimestamp":1782764768,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260629:nFWN43113I:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4082","BK4139","BK4211","BK4168","PLBN","BK4133","PRPH","PHIXF","PHASQ","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640380967","title":"ProPhase Labs FY25 net loss narrows to $14.7 million; revenue falls 35.8% to $4.3 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2640380967","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640380967?lang=en_us&edition=fundamental","pubTime":"2026-06-02 05:14","pubTimestamp":1780348494,"startTime":"0","endTime":"0","summary":"ProPhase Labs posted a net loss of USD 14.7 million, or USD 1.74 per share, for fiscal 2025, narrowing from a USD 53.4 million loss.Revenue fell 35.8% to USD 4.3 million, reflecting a USD 2.4 million drop in consumer products as it reduced TK Supplements sales.Gross profit was USD 1.4 million, swinging from a USD 0.2 million gross margin loss; consumer products gross margin rose 7.7 percentage points to 39.9%.General and administrative expense dropped to USD 19.3 million from USD 37.9 million, while interest expense climbed to USD 6.9 million.Diagnostics subsidiaries halted COVID-19 testing in May 2025, filed Chapter 11 on Sept. 22, 2025, and were deconsolidated; cash was about USD 90,000 at year-end.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260601:nNDLbzGp5R:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2635267030","title":"ProPhase Labs delays Q1 10-Q filing as 2025 audit process continues","url":"https://stock-news.laohu8.com/highlight/detail?id=2635267030","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2635267030?lang=en_us&edition=fundamental","pubTime":"2026-05-16 04:37","pubTimestamp":1778877444,"startTime":"0","endTime":"0","summary":"ProPhase Labs filed a late notice for its quarterly report for period ended March 31, 2026, citing inability to file on time without unreasonable effort or expense.Delay tied to extra time needed to complete year-end reporting work on its annual report on Form 10-K, including completion of ongoing audit procedures for year ended Dec. 31, 2025.Quarterly report expected within five calendar days of prescribed due date, with filing planned to follow completion of the 2025 audit.Notice indicated no anticipated significant change in results of operations versus corresponding prior-year quarter.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProPhase Labs Inc. published the original content used to generate this news brief via EDGAR, the Ele","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260515:nNDL9pdhnY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627873902","title":"ProPhase Labs FY25 net loss narrows to $13.4 million; revenue drops 27.6% to $4.9 million","url":"https://stock-news.laohu8.com/highlight/detail?id=2627873902","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627873902?lang=en_us&edition=fundamental","pubTime":"2026-04-15 21:07","pubTimestamp":1776258443,"startTime":"0","endTime":"0","summary":"ProPhase Labs posted a net loss of $13.4 million, narrowing from a year-earlier net loss of $53.4 million.Adjusted EBITDA improved to a loss of $6.5 million from a loss of $17.9 million.Crown Medical Collections platform expanded to $201.2 million in gross claims, with $79.9 million in active settlement negotiations and estimated net recoveries of $50 million-$60 million after contingency fees.Management expects the receivables platform to begin generating meaningful cash flow in Q3.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nNDL7hGJkj:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2210149790.SGD","LU2095319765.USD","BK4585","SG9999014005.SGD","SG9999014021.USD","IE00BN0W2V16.EUR","IE00BN0W2T93.GBP","BK4007","SG9999014013.SGD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","IE00BKPKM429.USD","SG9999014039.USD","LU0314104364.USD","NDAQ","BK4112","IE00B3QW5Z07.USD","IE00BN0W2W23.USD","LU2210150020.SGD","PRPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627894287","title":"Prophase Labs Reports Year-End 2025 Results, Highlights Accelerating Settlement Activity and Investment-Ready Crown Medical Collections Platform","url":"https://stock-news.laohu8.com/highlight/detail?id=2627894287","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627894287?lang=en_us&edition=fundamental","pubTime":"2026-04-15 21:05","pubTimestamp":1776258301,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nTUA8DNNSX:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","PRPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2627287660","title":"Prophase Labs Inc - Estimates Potential Net Recoveries of $50-$60 Mln After Contingency Fee","url":"https://stock-news.laohu8.com/highlight/detail?id=2627287660","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2627287660?lang=en_us&edition=fundamental","pubTime":"2026-04-15 21:05","pubTimestamp":1776258301,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260415:nTUA8DNNSX:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2622803226","title":"ProPhase Labs FY2025 10-K filing slips; report due to income tax provision work and ongoing audit procedures","url":"https://stock-news.laohu8.com/highlight/detail?id=2622803226","media":"Reuters","labels":["dataReport","event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2622803226?lang=en_us&edition=fundamental","pubTime":"2026-03-28 05:11","pubTimestamp":1774645871,"startTime":"0","endTime":"0","summary":"ProPhase Labs filed a Form 12b-25 notice stating it will not timely file its annual report on Form 10-K for the period ended Dec. 31, 2025.The company cited additional time needed to complete its year-end financial reporting process, including its income tax provision and ongoing audit procedures.ProPhase Labs said it expects to file the Form 10-K within the 15-day extension period permitted under SEC Rule 12b-25.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProPhase Labs Inc. published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission , on March 27, 2026, and is solely responsible for the information c","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260327:nNDL7PblJy:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport,event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620742465","title":"BRIEF-Prophase Labs Provides Business Update Highlighting Advancing Crown Medical Collections Activity","url":"https://stock-news.laohu8.com/highlight/detail?id=2620742465","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620742465?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:14","pubTimestamp":1773749663,"startTime":"0","endTime":"0","summary":"BRIEF-Prophase Labs Provides Business Update Highlighting Advancing Crown Medical Collections ActivityMarch 17 (Reuters) - Prophase Labs Inc PRPH.PK:PROPHASE LABS PROVIDES BUSINESS UPDATE HIGHLIGHTING","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nTUA33LHYY:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2620055421","title":"ProPhase Labs reports Crown Medical Collections talks with more than 250 payors and financing interest for receivables-backed deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2620055421","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2620055421?lang=en_us&edition=fundamental","pubTime":"2026-03-17 20:03","pubTimestamp":1773748989,"startTime":"0","endTime":"0","summary":"ProPhase Labs reports Crown Medical Collections talks with more than 250 payors and financing interest for receivables-backed deal. ProPhase said Crown Medical Collections is engaging with more than 250 insurance payors. The company said about 100 of these matters are in active settlement discussions. ProPhase said it is in discussions with institutional capital providers about potential receivables-backed financing structures expected to be without recourse to the parent company.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260317:nNDL8l1QDV:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","BK4588","LU2210149790.SGD","LU2095319765.USD","NDAQ","BK4007","LU0314104364.USD","SG9999014013.SGD","IE00BN0W2V16.EUR","SG9999014039.USD","IE00B64PRP62.GBP","IE00B3QW5Z07.USD","SG9999014021.USD","IE00BKPKM429.USD","IE00BGHQF748.EUR","SG9999014005.SGD","BK4112","LU2210150020.SGD","BK4585","PRPH","IE00BN0W2T93.GBP","IE00BN0W2W23.USD","SMFX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2612947779","title":"ABL Diagnostics Says ProPhase LOI Has Expired and Talks Have Ended","url":"https://stock-news.laohu8.com/highlight/detail?id=2612947779","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2612947779?lang=en_us&edition=fundamental","pubTime":"2026-02-19 15:05","pubTimestamp":1771484739,"startTime":"0","endTime":"0","summary":"ABL Diagnostics SA said a previously disclosed non-binding letter of intent between ProPhase Labs, Inc. and Advanced Biological Laboratories S.A. has expired, and the parties are no longer pursuing the proposed transaction. The company added it will continue exploring options to expand the ABL group, including ABL Diagnostics, into the United States.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260219:nNDL5WyJq2:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4007","PRPH"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611991651","title":"ProPhase Labs Explores Strategic Options for BE-Smart Test","url":"https://stock-news.laohu8.com/highlight/detail?id=2611991651","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611991651?lang=en_us&edition=fundamental","pubTime":"2026-02-14 06:53","pubTimestamp":1771023209,"startTime":"0","endTime":"0","summary":"An update from Prophase Labs ( ($PRPH) ) is now available. On February 3, 2026, ProPhase Labs, Inc. announced it had begun exploring a potential sa...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prophase-labs-explores-strategic-options-for-be-smart-test?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prophase-labs-explores-strategic-options-for-be-smart-test?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU2264538146.SGD","LU0823414551.USD","LU0444973449.USD","LU0444971666.USD","LU0823414478.USD","LU1815336760.USD","LU0957808578.USD","BK4588","BK4182","BK4541","LU2506951792.HKD","LU2543165471.USD","LU2357125470.USD","LU1064131342.USD","LU1642822529.SGD","LU2249611893.SGD","BK4585","BK4007","LU1988902786.USD","LU0476273544.USD","PRPH","LU2294711713.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2611248196","title":"ProPhase Labs Hosts Investor Webinar on Growth Portfolio","url":"https://stock-news.laohu8.com/highlight/detail?id=2611248196","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2611248196?lang=en_us&edition=fundamental","pubTime":"2026-02-14 06:26","pubTimestamp":1771021572,"startTime":"0","endTime":"0","summary":"An announcement from Prophase Labs ( ($PRPH) ) is now available. On February 2, 2026, ProPhase Labs, Inc. announced it would host an investor webin...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prophase-labs-hosts-investor-webinar-on-growth-portfolio?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prophase-labs-hosts-investor-webinar-on-growth-portfolio?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2609130654","title":"ProPhase Labs Inc. Unveils Strategic Plans for BE-Smart Esophageal Cancer Test and Proposed ABL Merger","url":"https://stock-news.laohu8.com/highlight/detail?id=2609130654","media":"Reuters","labels":["corporation","productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2609130654?lang=en_us&edition=fundamental","pubTime":"2026-02-05 22:03","pubTimestamp":1770300187,"startTime":"0","endTime":"0","summary":"Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProPhase Labs Inc. published the original content used to generate this news brief on February 05, 2026, and is solely responsible for the information contained therein.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260205:nNDL93tVMm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2608850861","title":"ProPhase Labs Hosts Exclusive Investor Webinar Showcasing Healthcare Innovations","url":"https://stock-news.laohu8.com/highlight/detail?id=2608850861","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2608850861?lang=en_us&edition=fundamental","pubTime":"2026-02-02 21:00","pubTimestamp":1770037211,"startTime":"0","endTime":"0","summary":"ProPhase Labs Inc. will host an exclusive live investor webinar and Q&A session on Tuesday, February 3, 2026, at 4:15 p.m. ET. The event, led by Chairman and CEO Ted Karkus and hosted by RedChip Companies, will provide insights into ProPhase's healthcare portfolio, including recent milestones in molecular diagnostics, genomics, and consumer health. The presentation will cover the BE-Smart Esophageal Cancer Test, strategic initiatives, and upcoming product launches. A live Q&A session will follow the presentation. Registration is available online.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProPhase Labs Inc. published the original content used to generate this news brief via GlobeNewswire  on February 02, 2026, and is solely respons","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260202:nNDL97zqTw:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SG9999014039.USD","LU2095319765.USD","BK4112","IE00B3QW5Z07.USD","BK4007","SG9999014005.SGD","LU2210149790.SGD","SG9999014021.USD","PRPH","IE00BKPKM429.USD","BK4588","LU0314104364.USD","IE00B64PRP62.GBP","IE00BGHQF748.EUR","LU2210150020.SGD","BK4585","SG9999014013.SGD","NDAQ"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606736717","title":"ProPhase Labs Issues Update on Crown Medical Collections","url":"https://stock-news.laohu8.com/highlight/detail?id=2606736717","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606736717?lang=en_us&edition=fundamental","pubTime":"2026-01-28 00:27","pubTimestamp":1769531278,"startTime":"0","endTime":"0","summary":"Prophase Labs ( ($PRPH) ) has issued an update. On January 26, 2026, ProPhase Labs, Inc. announced it had issued an operational update on the progr...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/prophase-labs-issues-update-on-crown-medical-collections?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/prophase-labs-issues-update-on-crown-medical-collections?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["PRPH","LU0029864427.USD","LU0310800379.SGD","LU1267930573.SGD","LU0211327993.USD","LU1267930490.SGD","BK4126","CCK","LU0128525929.USD","LU0211328371.USD","LU0708994859.HKD","LU0128526141.USD","LU1803068623.USD","LU0310799852.SGD","LU0029874061.USD","BK4007","LU1892829315.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606072212","title":"ProPhase Labs Advances Chapter 11 Collections With 50 Insurance Settlements Nearing Completion","url":"https://stock-news.laohu8.com/highlight/detail?id=2606072212","media":"Reuters","labels":["event"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606072212?lang=en_us&edition=fundamental","pubTime":"2026-01-26 20:01","pubTimestamp":1769428891,"startTime":"0","endTime":"0","summary":"ProPhase Labs Inc. has provided an update on its Crown Medical Collections initiative, which is focused on recovering legacy COVID-19 testing receivables through its laboratory subsidiaries currently in Chapter 11 proceedings. Crown Medical, acting as special counsel, is in settlement negotiations with over 250 insurance payors, with approximately 50 cases in advanced settlement stages and expected to close within the next 30 to 90 days. The anticipated recoveries are projected to significantly improve near-term liquidity, supporting ongoing operations and a court-supervised restructuring process. Net cash recoveries after fees and costs could exceed $50 million, though the final amount remains subject to negotiations and court processes. Remaining proceeds, after satisfying subsidiary creditor obligations, are expected to benefit ProPhase Labs, Inc.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide ac","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDLc4qHpG:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"event","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00B3QW5Z07.USD","BK4585","BK4112","IE00BKPKM429.USD","LU2210149790.SGD","SG9999014005.SGD","LU0314104364.USD","IE00B64PRP62.GBP","SG9999014013.SGD","SG9999014039.USD","LU2210150020.SGD","BK4588","IE00BGHQF748.EUR","NDAQ","SG9999014021.USD","PRPH","BK4007","LU2095319765.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606205212","title":"Prophase Labs Provides Crown Medical Collections Update; 250+ Insurance Payors Engaged, Approximately 50 Matters in Advanced Settlement Posture","url":"https://stock-news.laohu8.com/highlight/detail?id=2606205212","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606205212?lang=en_us&edition=fundamental","pubTime":"2026-01-26 20:00","pubTimestamp":1769428803,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nTUA25YDZL:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["PRPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2606292341","title":"ProPhase Labs Secures $10 Million Equity Line With Generating Alpha","url":"https://stock-news.laohu8.com/highlight/detail?id=2606292341","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2606292341?lang=en_us&edition=fundamental","pubTime":"2026-01-26 15:26","pubTimestamp":1769412364,"startTime":"0","endTime":"0","summary":"ProPhase Labs Inc. has entered into a Stock Purchase Agreement with Generating Alpha Ltd., granting the company access to an equity line facility of up to $10 million. Under the agreement, ProPhase Labs can elect to sell shares of its common stock to the investor over time, at its own discretion. As part of the commitment fee for this arrangement, the company has issued 549,105 shares of common stock and a prefunded warrant to acquire up to 240,369 additional shares, with the warrant exercisable at no cost on a cashless basis. The securities were issued in reliance on exemptions from registration under Section 4 of the Securities Act and Regulation D.Disclaimer: This news brief was created by Public Technologies  using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ProPhase Labs Inc. published the origi","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260126:nNDL19H0My:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PRPH","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"websiteUrl":"http://www.prophaselabs.com","description":"ProPhase Labs, Inc. develops and commercializes novel drugs, dietary supplements, and compounds in the United States. It operates through two segments: Diagnostic Services and Consumer Products. The company provides a range of TK supplements, including Legendz XL for male sexual health; and Triple Edge XL, an energy and stamina booster. It offers contract manufacturing services, such as product development, pre-commercialization, production, warehousing, and distribution; COVID-19 diagnostic information services to a range of customers, including health plans, third party payers, and government organizations; and respiratory pathogen panel molecular and DNA testing services, as well as personal genomics products and services. In addition, the company involved in the research, development, manufacture, distribution, marketing, and sale of over the counter (OTC) consumer healthcare products and dietary supplements; and retail operations. The company was formerly known as The Quigley Corporation. ProPhase Labs, Inc. was founded in 1989 and is headquartered in Garden City, New York.","exchange":"PINK LIMITED","name":"ProPhase Labs, Inc.","nameEN":"ProPhase Labs, Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.45.0","shortVersion":"4.45.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"ProPhase Labs, Inc.(PRPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest ProPhase Labs, Inc.(PRPH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"ProPhase Labs, Inc.,PRPH,ProPhase Labs, Inc.股票,ProPhase Labs, Inc.股票老虎,ProPhase Labs, Inc.股票老虎国际,ProPhase Labs, Inc.行情,ProPhase Labs, Inc.股票行情,ProPhase Labs, Inc.股价,ProPhase Labs, Inc.股市,ProPhase Labs, Inc.股票价格,ProPhase Labs, Inc.股票交易,ProPhase Labs, Inc.股票购买,ProPhase Labs, Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"ProPhase Labs, Inc.(PRPH),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest ProPhase Labs, Inc.(PRPH) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction